Drug Eluting Stent: Clinical Trials

1 trial for Drug Eluting Stent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Drug Eluting Stent: new trials by email Literature Review of Drug Eluting Stent trials Research Report on Drug Eluting Stent

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease
1 month DAPT, 6 months DAPT - Coronary Disease, Drug Eluting Stent
Phase 4UnknownShanghai MicroPort Medical (Group) Co., Ltd.17202019-06-012020-09-09

Narrower conditions

Coronary Disease (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Myocardial Ischemia (1)  ·  Vascular Diseases (1)

Interventions

2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1)

Sponsors

Shanghai MicroPort Medical (Group) Co., Ltd. (1)

Countries

China (1)

Top investigators

Yaling Han, MD (1)

Results publications

PMID 34503738, PMID 34503739